- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | Q3 2024 · Jun 30, 2024 | $4.78B |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | $3.61B |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2023 | $4.61B |
| Current Liabilities | Q3 2024 · Jun 30, 2024 | $1.1B |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $1.01B |
| Current Liabilities restated | Q3 2024 · Jun 30, 2023 | $1.53B |
| Total Liabilities | Q3 2024 · Jun 30, 2024 | $5.73B |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $6.27B |
| Total Liabilities restated | Q3 2024 · Jun 30, 2023 | $6.17B |
| Current Assets | Q3 2024 · Jun 30, 2024 | $2.92B |
| Current Assets | Q3 2024 · Mar 31, 2024 | $2.52B |
| Current Assets restated | Q3 2024 · Jun 30, 2023 | $2.69B |
| Total Assets | Q3 2024 · Jun 30, 2024 | $10.51B |
| Total Assets | Q3 2024 · Mar 31, 2024 | $9.88B |
| Total Assets restated | Q3 2024 · Jun 30, 2023 | $10.78B |
| Net Income | Q3 2024 · Jun 30, 2024 | −$1.07B |
| Net Income | Q3 2024 · Mar 31, 2024 | −$101M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$1.07B |
| Net Income | Q3 2024 · Mar 31, 2023 | −$227M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$146M |
| Shares Outstanding | Q3 2024 · Apr 25, 2024 | 180.98M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 182M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 181M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 181M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 180M sh |
| Capex | Q3 2024 · Mar 31, 2024 | $252M |
| Capex | Q3 2024 · Mar 31, 2023 | $455M |
| Operating Cash Flow | Q3 2024 · Mar 31, 2024 | $54M |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | $58M |
| Short Term Debt | Q3 2024 · Mar 31, 2024 | $47M |
| Short Term Debt | Q3 2024 · Jun 30, 2023 | $536M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $162M |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $280M |
| Eps Diluted | Q3 2024 · Mar 31, 2024 | −$0.56 |
| Eps Diluted | Q3 2024 · Mar 31, 2024 | −$5.87 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$1.26 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.81 |
| Eps Basic | Q3 2024 · Mar 31, 2024 | −$0.56 |
| Eps Basic | Q3 2024 · Mar 31, 2024 | −$5.87 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$1.26 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.81 |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $214M |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $669M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $190M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $612M |
| Rd Expense | Q3 2024 · Mar 31, 2024 | $4M |
| Rd Expense | Q3 2024 · Mar 31, 2024 | $12M |
| Rd Expense | Q3 2024 · Mar 31, 2023 | $13M |
| Operating Income | Q3 2024 · Mar 31, 2024 | −$17M |
| Operating Income | Q3 2024 · Mar 31, 2024 | −$855M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$235M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$37M |
| Gross Profit | Q3 2024 · Mar 31, 2024 | $229M |
| Gross Profit | Q3 2024 · Mar 31, 2024 | $569M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $180M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $825M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2024 | $845M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2024 | $2.51B |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $857M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $2.38B |
| Revenue | Q3 2024 · Mar 31, 2024 | $1.07B |
| Revenue | Q3 2024 · Mar 31, 2024 | $3.08B |
| Revenue | Q3 2024 · Mar 31, 2023 | $1.04B |
| Revenue | Q3 2024 · Mar 31, 2023 | $3.21B |